Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: scott_jiminez who wrote (1102)	3/16/2000 4:17:00 AM
From: gerald tseng	Read Replies (1) \| Respond to of 4474

Scott: Thanks for elaboration. I will be looking into these companies. I don;t think the device companies would have the same power as Genomic company though. However, the beauty of these companies is being small cap value with regards to their potential. I really like ARIA, I think they are the natural next-step after the competion of Genomic Database. Do you have an opionion on CLPA?? Thanks.

To: scott_jiminez who wrote (1102)	3/25/2000 9:50:00 PM
From: wontgetfooledagin	Read Replies (2) \| Respond to of 4474

several months ago i was approached by an inventor/ceo/ physician who had 17 patents on a few different size syringes. he was trying to raise money privately. after i looked into the market i saw an obvious huge need for safety syringes. in fact the problem is so bad in california hospitals the state was in the process of making safety syringes mandatory. clearly, this fellows biggest obstacle was marketing. after looking into companies who control these markets it seemed like a tough market to penetrate domestically. according to this fellow becton dickinson and j&j tried to crush his little company. it makes sense that those types of partnerships could be risky. it is my understanding that in order to win contracts with the world health organization companies are expected to provide products at or near cost. i passed on this gentlemans company for these reasons and price. scott since my first encounter with you i have been watching your posts and it is clear you are knowledable and think thru your investment decisions very well. which is why i would like to talk with you more regarding unvc. i have a ton of research on the safety syringe market i would like to share.